NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 55.28 Thousand USD | -53.76% |
| 2022 | 119.55 Thousand USD | -41.07% |
| 2021 | 202.89 Thousand USD | -20.22% |
| 2020 | 254.32 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q3 | 209.91 Thousand USD | 0.0% |
| 2024 Q1 | 20.98 Thousand USD | 0.0% |
| 2023 Q3 | 88.91 Thousand USD | -27.05% |
| 2023 Q4 | 55.28 Thousand USD | -37.83% |
| 2023 FY | 55.28 Thousand USD | -53.76% |
| 2023 Q1 | 153.72 Thousand USD | 28.58% |
| 2023 Q2 | 121.89 Thousand USD | -20.7% |
| 2022 FY | 119.55 Thousand USD | -41.07% |
| 2022 Q1 | 173.31 Thousand USD | -14.58% |
| 2022 Q4 | 119.55 Thousand USD | -13.34% |
| 2022 Q3 | 137.95 Thousand USD | -11.59% |
| 2022 Q2 | 156.04 Thousand USD | -9.97% |
| 2021 Q3 | 206.96 Thousand USD | -7.34% |
| 2021 Q1 | 238.97 Thousand USD | -6.04% |
| 2021 Q2 | 223.35 Thousand USD | -6.54% |
| 2021 FY | 202.89 Thousand USD | -20.22% |
| 2021 Q4 | 202.89 Thousand USD | -1.97% |
| 2020 Q4 | 254.32 Thousand USD | -5.6% |
| 2020 Q1 | 298.32 Thousand USD | 0.0% |
| 2020 Q2 | 284.23 Thousand USD | -4.72% |
| 2020 FY | 254.32 Thousand USD | 0.0% |
| 2020 Q3 | 269.41 Thousand USD | -5.22% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | -100.0% |
| 2018 Q3 | 2.05 Million USD | 0.0% |
| 2018 Q2 | 2.05 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | 12.5 Thousand USD | 0.0% |
| 2012 Q4 | 12.5 Thousand USD | 0.0% |
| 2012 Q2 | 12.5 Thousand USD | 0.0% |
| 2012 Q1 | - USD | -100.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | 12.5 Thousand USD | 0.0% |
| 2011 Q3 | 12.5 Thousand USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acutus Medical, Inc. | 32.65 Million USD | 99.831% |
| Cerus Corporation | 59.79 Million USD | 99.908% |
| OrthoPediatrics Corp. | 13.45 Million USD | 99.589% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 94.564% |
| Talis Biomedical Corporation | 16.78 Million USD | 99.671% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 96.365% |
| Inogen, Inc. | 18.27 Million USD | 99.697% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 98.633% |
| CVRx, Inc. | 30.38 Million USD | 99.818% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -360.7% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.941% |
| Venus Concept Inc. | 70.79 Million USD | 99.922% |
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 99.847% |
| Bioventus Inc. | 366.99 Million USD | 99.985% |
| BrainsWay Ltd. | 239 Thousand USD | 76.869% |
| Envoy Medical, Inc. | 404 Thousand USD | 86.316% |
| electroCore, Inc. | 537 Thousand USD | 89.705% |
| IceCure Medical Ltd | 376 Thousand USD | 85.297% |
| Lucid Diagnostics Inc. | 199 Thousand USD | 72.219% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | 84.801% |
| MaxCyte, Inc. | 17.96 Million USD | 99.692% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| PAVmed Inc | 2.96 Million USD | 98.132% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 99.11% |
| RxSight, Inc. | 1.21 Million USD | 95.435% |
| Sight Sciences, Inc. | 31.7 Million USD | 99.826% |
| SI-BONE, Inc. | 36.06 Million USD | 99.847% |
| TELA Bio, Inc. | 40.51 Million USD | 99.864% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 95.556% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.896% |
| LivaNova PLC | 568.54 Million USD | 99.99% |
| 908 Devices Inc. | 3.92 Million USD | 98.593% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.989% |
| Nemaura Medical Inc. | 3.08 Million USD | 98.21% |
| NeuroPace, Inc. | 56.95 Million USD | 99.903% |
| LENSAR, Inc. | 1.75 Million USD | 96.841% |
| Apyx Medical Corporation | 33.18 Million USD | 99.833% |
| Cutera, Inc. | 418.69 Million USD | 99.987% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 99.633% |
| BioSig Technologies, Inc. | 103 Thousand USD | 46.326% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 99.795% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 99.444% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.996% |
| Axonics, Inc. | 25.84 Million USD | 99.786% |
| Outset Medical, Inc. | 134.59 Million USD | 99.959% |
| IRIDEX Corporation | 1.75 Million USD | 96.843% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.892% |
| IRadimed Corporation | 1.61 Million USD | 96.577% |
| Tivic Health Systems, Inc. | 176 Thousand USD | 68.589% |
| INVO Bioscience, Inc. | 6.77 Million USD | 99.184% |
| Telesis Bio, Inc. | 5.26 Million USD | 98.951% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 99.074% |
| Varex Imaging Corporation | 464.2 Million USD | 99.988% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.909% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 90.598% |
| Pulmonx Corporation | 35.08 Million USD | 99.842% |
| Dynatronics Corporation | 3.25 Million USD | 98.303% |
| Modular Medical, Inc. | 817 Thousand USD | 93.233% |
| ReShape Lifesciences Inc. | 151 Thousand USD | 63.388% |
| Semler Scientific, Inc. | 70 Thousand USD | 21.023% |
| InMode Ltd. | 6.61 Million USD | 99.164% |
| Bruker Corporation | 1.14 Billion USD | 99.995% |
| Cytosorbents Corporation | 2.54 Million USD | 97.826% |
| DexCom, Inc. | 2.57 Billion USD | 99.998% |
| Align Technology, Inc. | 96.96 Million USD | 99.943% |
| Viveve Medical, Inc. | 5.12 Million USD | 98.921% |
| ZimVie Inc. | 508.79 Million USD | 99.989% |
| Movano Inc. | 15.00 USD | -368460.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 99.695% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.986% |
| Profound Medical Corp. | 4.97 Million USD | 98.889% |
| Insulet Corporation | 1.36 Billion USD | 99.996% |
| enVVeno Medical Corporation | 1.06 Million USD | 94.804% |
| Surmodics, Inc. | 29.4 Million USD | 99.812% |
| iCAD, Inc. | 273 Thousand USD | 79.749% |
| Nuwellis, Inc. | 221 Thousand USD | 74.985% |
| Biotricity, Inc. | 10.85 Million USD | 99.491% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 99.842% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 91.492% |
| InspireMD, Inc. | 1.03 Million USD | 94.674% |
| PAVmed Inc. | 2.96 Million USD | 98.132% |
| BIOLASE, Inc. | 13.98 Million USD | 99.605% |
| Beyond Air, Inc. | 14.72 Million USD | 99.624% |
| FONAR Corporation | 37.92 Million USD | 99.854% |
| AxoGen, Inc. | 46.6 Million USD | 99.881% |
| Vivani Medical, Inc. | 19.31 Million USD | 99.714% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.876% |
| Inari Medical, Inc. | 30.35 Million USD | 99.818% |
| UFP Technologies, Inc. | 28 Million USD | 99.803% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 87.263% |
| Tenon Medical, Inc. | 428 Thousand USD | 87.083% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 94.483% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 97.431% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.997% |
| Sintx Technologies, Inc. | 3.68 Million USD | 98.501% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 99.851% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 90.598% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 90.724% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.994% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.989% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 90.892% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | 40.224% |
| Hyperfine, Inc. | 64 Thousand USD | 13.619% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.971% |
| Biomerica, Inc. | 459 Thousand USD | 87.956% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 87.701% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | 70.901% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.927% |